ACME Laboratories (DHA:ACMELAB) COGS-to-Revenue : 0.57 (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is ACME Laboratories COGS-to-Revenue?

ACME Laboratories's Cost of Goods Sold for the three months ended in Mar. 2024 was BDT4,595 Mil. Its Revenue for the three months ended in Mar. 2024 was BDT8,004 Mil.

ACME Laboratories's COGS to Revenue for the three months ended in Mar. 2024 was 0.57.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. ACME Laboratories's Gross Margin % for the three months ended in Mar. 2024 was 42.60%.

ACME Laboratories COGS-to-Revenue Historical Data

The historical data trend for ACME Laboratories's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ACME Laboratories COGS-to-Revenue Chart

ACME Laboratories Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

COGS-to-Revenue

Get a 7-Day Free Trial

0.61

0.62

0.61

0.60

0.59

ACME Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.60	0.58	0.59	0.59	0.57

ACME Laboratories COGS-to-Revenue Calculation

ACME Laboratories's COGS to Revenue for the fiscal year that ended in Jun. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	16016.001	/	26947.708
	=	0.59

ACME Laboratories's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	4594.953	/	8004.48
	=	0.57

ACME Laboratories (DHA:ACMELAB) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

ACME Laboratories's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	4594.953 / 8004.48
	=	42.60 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

ACME Laboratories COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of ACME Laboratories's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

ACME Laboratories (DHA:ACMELAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ACME Laboratories Ltd (DHA:ACMELAB) » Definitions » COGS-to-Revenue

Traded in Other Exchanges

N/A

Address

1/4, Kallayanpur, Mirpur Road, Court de la ACME, Dhaka, BGD, 1207

Website

https://www.acmeglobal.com

ACME Laboratories Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products in Bangladesh. The company offers pharmaceutical, ayurvedic, herbal, nutraceutical products, and veterinary products. It produces various forms of dosage including tablet, capsule, dry syrup, cream, ointment, powder and injection among others.

ACME Laboratories (DHA:ACMELAB) Headlines

No Headlines